Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2027
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis ; volume:35 ; number:8 ; day:31 ; month:7 ; year:2017 ; pages:845-858 ; date:8.2017
PharmacoEconomics ; 35, Heft 8 (31.7.2017), 845-858, 8.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Buchanan, James
- Contributor
-
Wordsworth, Sarah
Clifford, Ruth
Robbe, Pauline
Taylor, Jenny C.
Schuh, Anna
Knight, Samantha J. L.
SpringerLink (Online service)
- DOI
-
10.1007/s40273-017-0519-z
- URN
-
urn:nbn:de:1111-201710252641
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Buchanan, James
- Wordsworth, Sarah
- Clifford, Ruth
- Robbe, Pauline
- Taylor, Jenny C.
- Schuh, Anna
- Knight, Samantha J. L.
- SpringerLink (Online service)
Other Objects (12)
Revealing a phenotypical appearance of ibrutinib resistance in patients with chronic lymphocytic leukaemia by flow cytometry
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Neutrophil biology in chronic lymphocytic leukaemia and infections
A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS)
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Expert consensus on the management of chronic lymphocytic leukaemia in Asia
Revealing a phenotypical appearance of ibrutinib resistance in patients with chronic lymphocytic leukaemia by flow cytometry
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Neutrophil biology in chronic lymphocytic leukaemia and infections
A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS)
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Expert consensus on the management of chronic lymphocytic leukaemia in Asia
Revealing a phenotypical appearance of ibrutinib resistance in patients with chronic lymphocytic leukaemia by flow cytometry
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Neutrophil biology in chronic lymphocytic leukaemia and infections
A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS)
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib